Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder

@article{McGough2005DexmethylphenidateEC,
  title={Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder},
  author={J. McGough and C. Pataki and Robert L Suddath},
  journal={Expert Review of Neurotherapeutics},
  year={2005},
  volume={5},
  pages={437 - 441}
}
Medications for attention deficit hyperactivity disorder (ADHD) currently represent the ninth largest segment of the CNS market by sales, with US$2.4 billion spent annually on this condition and 40% annual growth. Stimulant medications remain the most effective ADHD therapies and provide robust improvement in ADHD symptoms in both youth and adults. Current prescribing practices favor extended release preparations due to increased convenience, compliance and tolerability with once-daily dosing… Expand
View on Taylor & Francis
ncbi.nlm.nih.gov
20 Citations
Background Citations
6
Results Citations
1

20 Citations

Citation Type

Citation Type

Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.
  • 17
  • PDF
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
  • 117
Duration of effect of oral long-acting stimulant medications for ADHD throughout the day
  • 28
Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents
  • 54
Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth.
  • S. Faraone, E. Giefer
  • Psychology, Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • 2007
  • 46
Neuropharmacology of Attention‐Deficit/Hyperactivity Disorder
Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence
  • M. Schlander
  • Medicine
  • Child and adolescent psychiatry and mental health
  • 2007
  • 22
Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults
  • 52
Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults
  • 19
Some side effects and effcts on physical activity of second-generation antipsychotics: A study in children and adolescents
  • 1
...
1
2
...

References

SHOWING 1-10 OF 45 REFERENCES
Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
  • 140
New Formulations of Stimulants for Attention-Deficit Hyperactivity Disorder
  • 56
New drugs for the treatment of attention-deficit/hyperactivity disorder
  • 13
Advances in the Pharmacotherapy of Attention‐Deficit‐Hyperactivity Disorder: Focus on Methylphenidate Formulations
  • 140
Stimulant medications : Current knowledge and unmet needs in pediatrics psychopharmacology
  • 196
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
  • 84
Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats
  • 34
Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications
  • 289
  • PDF
Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action
  • 61
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
  • 827
  • PDF
...
1
2
3
4
5
...